Chambliss Clinical Trials, LLC
Montgomery, Alabama 36106
2 studies enrolling now · 9 studies all time
What they study most
Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Inflammation, Obesity, Overweight, Type 2 Diabetes
Studies at this site
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity — Recruiting now
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — Running, not enrolling
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight — Starting soon
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight — Completed
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) — Completed
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight — Completed
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed